BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced…
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced…
. - Data from completed Phase I part of SHORE study in advanced colorectal cancer (CRC) to be presented at upcoming ASC…
BIOTRONIK, a leading manufacturer of innovative medical technology, announced today that enrollment has been completed f…